Optiver Holding
AURA icon

Optiver Holding’s Aura Biosciences AURA Stock Holding History

Optiver Holding’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.62K Sell
392
-192
-33% -$1.1K ﹤0.01% 1740
2025
Q4 		$3.18K Buy
+584
New +$3.47K ﹤0.01% 1715

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Optiver Holding's AURA Position: Q1 2026 in Review

Optiver Holding reduced its Aura Biosciences (AURA) stake by 33% in Q1 2026, selling an estimated $1.1K and leaving 392 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

Optiver Holding first reported a position in AURA in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.18K in Q4 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Optiver Holding held 392 shares of Aura Biosciences worth $2.62K as of Q1 2026.
  • Optiver Holding sold 192 Aura Biosciences shares in Q1 2026, an estimated $1.1K.
  • Aura Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1740 holding.
  • Optiver Holding first reported a position in Aura Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Optiver Holding's Aura Biosciences position peaked at $3.18K in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.